优化静脉疾病管理:跨国静脉学专家共识
Chronic venous disease and varicose veins (VV) are highly prevalent yet remain inconsistently managed despite existing guidelines, with variability in treatment selection, patient stratification, and use of conservative therapies.…
要点
- 治疗决策应主要基于症状和生活质量,而非仅解剖结构。
- 症状性静脉曲张支持腔内手术,激光与射频消融等效。
- 地奥司明类静脉活性药物联合压力治疗可跨CEAP分级缓解症状。
核心结论
- 共识强调静脉疾病治疗应以症状和生活质量为主要驱动,而非仅依据解剖。
- 症状性疾病支持腔内手术,激光和射频消融被认为等效。
- 地奥司明类静脉活性药物常联合压力治疗,可跨CEAP分级缓解症状,但保守治疗依从性有限。
研究设计与样本
- 采用类德尔菲法,由来自欧洲、北非和中亚15个国家的38名静脉学专家参与。
主要发现
- 34条拟议陈述中30条(88%)达成共识。
- 专家组强调治疗决策应主要基于症状和生活质量,而非仅解剖。
- 症状性疾病支持腔内手术,激光和射频消融被认为等效。
- 地奥司明类静脉活性药物常联合压力治疗,可跨CEAP分级缓解症状,但保守治疗依从性有限。
关键数值与推荐
- 共识定义为≥75%同意。
- 34条陈述中30条(88%)达成共识。
- 症状性静脉曲张的腔内激光消融和射频消融被认为等效。
- 地奥司明类静脉活性药物可跨CEAP分级用于症状缓解,常联合压力治疗。
临床怎么用
- 临床决策应优先评估症状和生活质量,而非仅依据解剖分类。
- 对有症状的静脉曲张,可选择腔内激光或射频消融。
- 可考虑地奥司明类静脉活性药物联合压力治疗缓解症状,但需关注依从性。
局限性
- 共识指出在风险分层、依从性和长期比较结局方面存在未满足需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic venous disease and varicose veins (VV) are highly prevalent yet remain inconsistently managed despite existing guidelines, with variability in treatment selection, patient stratification, and use of conservative therapies. This multinational initiative sought to establish expert consensus on key clinical questions in venous disease management. A Delphi-like process involved 38 phlebologists from 15 countries across Europe, North Africa, and Central Asia. Four thematic workshops addressed interventional and conservative approaches for both chronic venous disease and VV. Twenty predefined questions were discussed, and resulting statements were rated on a 5-point Likert scale, with consensus defined as ≥75% agreement. Of 34 proposed statements, 30 (88%) achieved consensus. The panel emphasized that treatment decisions should be driven primarily by symptoms and quality of life rather than anatomy alone. Endovenous procedures were supported for symptomatic disease, with endovenous laser ablation and radiofrequency ablation considered equivalent for VV. Diosmin-based venoactive drugs, often combined with compression, were endorsed across Clinical, Etiologic, Anatomic, and Pathophysiologic classes for symptom relief, although adherence to conservative therapy remains limited. This consensus provides practical guidance for individualized care and highlights unmet needs in risk stratification, adherence, and long-term comparative outcomes.
引用
- Matei SC, Nikolov N, Popović M, et al. Optimizing the management of venous disease: Expert consensus from a multinational panel of phlebology specialists. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42551587. doi:10.1016/j.jvsv.2026.102593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。